Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shen-gu granule
- Development stage
- Phase 4
- Lead developer
- Wuhan Jun'an Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shen-Gu granule (also known as Kidney-Bone granule) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Wuhan Jun'an Pharmaceutical. The product is designed based on the TCM principle of "tonifying the kidney to strengthen the bone," targeting bone metabolism and joint health. It is primarily indicated for the treatment of osteoarthritis and the prevention and treatment of glucocorticoid-induced osteoporosis (GIOP). The drug is currently marketed in China, and post-marketing clinical trials have been conducted to further evaluate its efficacy in improving bone mineral density and alleviating symptoms of joint degeneration. These studies include reevaluations registered in the Chinese Clinical Trial Registry (ChiCTR) to assess its performance in specific patient populations, such as those with secondary osteoporosis or chronic joint disease.
- Brand names
- Shen-Gu granule
- Other names
- kidney-bone granuleShengu granule
Beyond the preview
Go deeper on shen-gu granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shen-gu granule.